Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Cash and Short Term Investments (Quarterly): 31.61M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 31.61M |
| June 30, 2023 | 45.56M |
| March 31, 2023 | 61.38M |
| December 31, 2022 | 53.11M |
| September 30, 2022 | 66.10M |
| June 30, 2022 | 90.15M |
| March 31, 2022 | 112.46M |
| December 31, 2021 | 135.10M |
| September 30, 2021 | 151.39M |
| June 30, 2021 | 171.02M |
| March 31, 2021 | 229.41M |
| Date | Value |
|---|---|
| December 31, 2020 | 126.03M |
| September 30, 2020 | 154.81M |
| June 30, 2020 | 171.62M |
| March 31, 2020 | 123.10M |
| December 31, 2019 | 148.07M |
| September 30, 2019 | 121.23M |
| June 30, 2019 | 133.88M |
| March 31, 2019 | 138.57M |
| December 31, 2018 | 89.49M |
| September 30, 2018 | 27.86M |
| December 31, 2017 | 29.42M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
31.61M
Minimum
Sep 2023
229.41M
Maximum
Mar 2021
118.11M
Average
124.56M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 5.619B |
| Axonics Inc | 332.81M |
| Johnson & Johnson | 26.22B |
| Boston Scientific Corp | 2.329B |
| Ambrx Biopharma Inc (DELISTED) | 225.26M |